1. Home
  2. LMFA vs VIVS Comparison

LMFA vs VIVS Comparison

Compare LMFA & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LM Funding America Inc.

LMFA

LM Funding America Inc.

HOLD

Current Price

$0.26

Market Cap

5.6M

Sector

Finance

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

HOLD

Current Price

$1.41

Market Cap

4.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMFA
VIVS
Founded
2008
2007
Country
United States
United States
Employees
19
9
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
4.9M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
LMFA
VIVS
Price
$0.26
$1.41
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
390.8K
59.3K
Earning Date
03-27-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
28.08
N/A
EPS
N/A
N/A
Revenue
$10,999,648.00
N/A
Revenue This Year
N/A
$42.38
Revenue Next Year
$22.58
$15.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$1.42
52 Week High
$5.14
$5.30

Technical Indicators

Market Signals
Indicator
LMFA
VIVS
Relative Strength Index (RSI) 31.48 30.04
Support Level N/A N/A
Resistance Level $0.44 $2.11
Average True Range (ATR) 0.04 0.10
MACD -0.01 -0.03
Stochastic Oscillator 7.48 0.18

Price Performance

Historical Comparison
LMFA
VIVS

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: